Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eli Gilboa

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Cancer Research|December 3, 2005
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblastsJaewoo Lee, Martin Fassnacht, Smita Nair, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Aptamer-Targeted Attenuation of IL-2 Signaling in CD8<sup>+</sup> T Cells Enhances Antitumor ImmunityAnugraha Rajagopalan, Alexey Berezhnoy, Brett Schrand, et al.
The Journal of Clinical Investigation|December 3, 2013
Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunityAlexey Berezhnoy, Iris Castro, Agata Levay, et al.
The Journal of Infectious Diseases|November 24, 2025
Vaccination against pathogens targeting cell-derived cryptic antigensEmily S Clark, Greta Garrido, Agata Levay, et al.
Blood|April 12, 2003
Synergy between tumor immunotherapy and antiangiogenic therapySmita Nair, David Boczkowski, Benjamin Moeller, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigenPaul R Hess, David Boczkowski, Smita K Nair, et al.
Research Square|March 31, 2025
KLF2 inhibition expands tumor-resident T cells and enhances tumor immunityEli Gilboa, Vineet Gupta, Darija Muharemagic, et al.
Cancer Research|November 13, 2003
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunitySandra Santulli-Marotto, Smita K Nair, Chris Rusconi, et al.
Research in Computational Molecular Biology : ... Annual International Conference, RECOMB ... : Proceedings. RECOMB (Conference : 2005- )|January 6, 2015
AptaCluster - A Method to Cluster HT-SELEX Aptamer Pools and Lessons from its ApplicationJan Hoinka, Alexey Berezhnoy, Zuben E Sauna, et al.
Macromolecular Bioscience|May 13, 2009
A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labelingJing Zhou, Boonchoy Soontornworajit, Jacob Martin, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Cancer Research|December 3, 2005
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblastsJaewoo Lee, Martin Fassnacht, Smita Nair, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Aptamer-Targeted Attenuation of IL-2 Signaling in CD8<sup>+</sup> T Cells Enhances Antitumor ImmunityAnugraha Rajagopalan, Alexey Berezhnoy, Brett Schrand, et al.
The Journal of Clinical Investigation|December 3, 2013
Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunityAlexey Berezhnoy, Iris Castro, Agata Levay, et al.
The Journal of Infectious Diseases|November 24, 2025
Vaccination against pathogens targeting cell-derived cryptic antigensEmily S Clark, Greta Garrido, Agata Levay, et al.
Blood|April 12, 2003
Synergy between tumor immunotherapy and antiangiogenic therapySmita Nair, David Boczkowski, Benjamin Moeller, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigenPaul R Hess, David Boczkowski, Smita K Nair, et al.
Research Square|March 31, 2025
KLF2 inhibition expands tumor-resident T cells and enhances tumor immunityEli Gilboa, Vineet Gupta, Darija Muharemagic, et al.
Cancer Research|November 13, 2003
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunitySandra Santulli-Marotto, Smita K Nair, Chris Rusconi, et al.
Research in Computational Molecular Biology : ... Annual International Conference, RECOMB ... : Proceedings. RECOMB (Conference : 2005- )|January 6, 2015
AptaCluster - A Method to Cluster HT-SELEX Aptamer Pools and Lessons from its ApplicationJan Hoinka, Alexey Berezhnoy, Zuben E Sauna, et al.
Macromolecular Bioscience|May 13, 2009
A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labelingJing Zhou, Boonchoy Soontornworajit, Jacob Martin, et al.
Pageof 8